<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/42C4AB31-4EFF-4C22-8F28-B1827BC2978C"><gtr:id>42C4AB31-4EFF-4C22-8F28-B1827BC2978C</gtr:id><gtr:name>Laval University</gtr:name><gtr:address><gtr:line1>Universite Laval</gtr:line1><gtr:line2>Sainte-Foy</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8B7C8B1B-87E1-482C-B0C7-5C9D4EEE8355"><gtr:id>8B7C8B1B-87E1-482C-B0C7-5C9D4EEE8355</gtr:id><gtr:name>European Cooperation in Science and Technology (COST)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Sch of Biosciences</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/42C4AB31-4EFF-4C22-8F28-B1827BC2978C"><gtr:id>42C4AB31-4EFF-4C22-8F28-B1827BC2978C</gtr:id><gtr:name>Laval University</gtr:name><gtr:address><gtr:line1>Universite Laval</gtr:line1><gtr:line2>Sainte-Foy</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8B7C8B1B-87E1-482C-B0C7-5C9D4EEE8355"><gtr:id>8B7C8B1B-87E1-482C-B0C7-5C9D4EEE8355</gtr:id><gtr:name>European Cooperation in Science and Technology (COST)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4466027A-D38D-409B-9089-1B9EECDC1C8A"><gtr:id>4466027A-D38D-409B-9089-1B9EECDC1C8A</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Loman</gtr:surname><gtr:orcidId>0000-0002-9843-8988</gtr:orcidId><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FJ014370%2F1"><gtr:id>CA111584-C9C1-459E-9DA9-8C50D4D776B6</gtr:id><gtr:title>Development of robust analytical pipelines for the analysis of microbial community data from clinical samples</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>MR/J014370/1</gtr:grantReference><gtr:abstractText>Cystic fibrosis is an inherited disease which affects around 9,000 people in the UK. It is a recessive disorder, meaning that both parents have to carry a faulty copy of a gene for a child to be affected. Approximately 1 in 25 people carry this copy. Cystic fibrosis dramatically shortens the life of those affected and almost half do not live beyond their 30s. Cystic fibrosis has a negative effect on many parts of the body, but it particularly affects the lungs. The result of the defective gene is that thick secretions cannot be effectively cleared from the lungs, resulting in the airways becoming congested and damaged.

This congestion results in frequent and severe exacerbations, sometimes requiring admission to hospital and treatment. We think exacerbations are often a result of infections, which may be caused by viruses and bacteria. One of the most common bacteria found is Pseudomonas aeruginosa. Microbiologists diagnose Pseudomonas by putting samples of sample onto plates and identifying the bacteria that grow in visible colonies. Often Pseudomonas is treated by antibiotics. Other bacteria may be found including Streptococcus and Staphylococcus.

However when looking for causes of exacerbations we are limited to finding pathogens that we know about, and which grow on the types of culture plates we use. It may be that other bacteria are present that we can't see because they do not grow easily. Sometimes those bacteria may be a cause. However, in a similar way to the human gut it may be that there are &amp;quot;good&amp;quot; and &amp;quot;bad&amp;quot; bacteria. It is known that certain types of bacteria can prevent other types infecting and therefore they may help protect against exacerbations.

A new technology utilises the idea of molecular barcodes which identify bacterial species from fragments of DNA in their cell. New instruments termed high-throughput sequencers permit these barcodes to be read from many samples easily and cheaply. This technology gives us a &amp;quot;parts list&amp;quot; of the bacterial species in a particular sample, and a rough idea of how frequently they occur. By reading this parts lists from patients with cystic fibrosis - when they are well, when they are very sick and when they are recovering, we may be able to tell the relative contribution of these unseen bacteria to the condition. For example a particular species increasing or reducing in abundance may be associated with recovery, giving us a potential therapeutic target.

We are also interesting in seeing how patients end up being colonised with particular, commonly seen bacteria. For example in our local patients, about 30% have a particular type of Pseudomonas infection called Midlands 1. However, very little is known about how it is that so many patients end up being infected by the same strain. We are now able to sequence all the DNA in a bacterial cell (the genome) which gives very high resolution view of how it has evolved. By comparing genomes of strains from different patients, we can help determine whether patients are infecting each other with the same strain, or whether the strains are quite different and come from many different sources. We can also see how the Pseudomonas evolves whilst it is in a patients lungs. Previous studies have shown that the Pseudomonas adapts to the specific environment, which may give us clues as to why people with the same cystic fibrosis mutation have different courses and end up with more hospital admissions or exacerbations than others.

The technology we are using is very new, and there are a number of difficulties with it before it can be a routine clinical test. One problem is that the machines generate plenty of sequencing &amp;quot;noise&amp;quot; which may look like species are present that aren't. I want to develop bioinformatics methods that try and increase the reliability of these techniques and generate information that would be useful for clinicians. We expect these techniques to enter the clinic within the next five years.</gtr:abstractText><gtr:technicalSummary>Cystic fibrosis (CF) affects around 9,000 people in the UK and is one of the most common inherited causes of premature death in adults. CF is inherited recessively from mutations found in the gene encoding for the CF transmembrane conductance regulator (CFTR), an epithelial chloride ion channel. In the respiratory tract, defective chloride ion transport leads to dehydration of the mucosal surface and consequent failure of the mucociliary escalator and plugging of the airways by hyperviscous mucus. Although, without treatment, premature death is inevitable, in developed countries management of the condition has resulted in a dramatically increased life expectancy with most patients now surviving into adult life. However, still only half of CF patients survive into their 40s.

During this fellowship, I aim to answer several key questions relating to chronic lung infection in cystic fibrosis, particularly:
- Is there a typical CF microbiota, and what is it like?
- How does the CF microbiota vary according to disease severity?
- Why has the Pseudomonas aeruginosa Midlands-1 clone established itself in our local cohort, and what are the routes of transmission? 
- How does Pseudomonas and other species evolve to adapt to the host during colonisation?

Answering these questions requires the concurrent addressing of important technical questions, specifically:
- Which benchtop instrument (Ion Torrent and Illumina MiSeq) performs best for 16S phylogenetic surveys?
- How well does whole-genome shotgun metagenomics perform compared to 16S analysis for phylogenetic surveys?
- What other information does whole-genome shotgun metagenomics provide compared to 16S?
- Are these methods statistically robust enough to enter clinical practice?
- Can 16S and metagenomics data be presented in a way useful for clinicians?

The methods employed will include use of 16S amplicon sequencing, whole-genome shotgun sequencing and whole-genome metagenomics (see case for support).</gtr:technicalSummary><gtr:potentialImpactText>This work will have a direct impact to patients, and in particular cystic fibrosis sufferers and their carers who will benefit from an enhanced understanding of the polymicrobial nature of CF lung infection and bronchiectasis. These findings will be useful for those looking at ways of developing novel therapeutics targeting the polymicrobial communities, for example probiotics and bacteriophage therapy. The community will be engaged through the CF patient representative, the CF patient group and the Heartlands CF newsletter and kept abreast of the progress of the study, as well as on the Heartlands CF website (www.heartlandscf.org). An executive summary plus the anonymised results of the final report will be sent to GPs of the subjects involved in the study and published on the CF website and publicised via the CF newsletter. The final report will also be offered for circulation to relevant organizations interested in cystic fibrosis, for example the Cystic Fibrosis Trust and Cystic Fibrosis Medicine.

The economic and social impact of this research will stem from the ability to make more timely and accurate diagnosis. A better understanding of the effects of antimicrobial treatments may lead to the development of more personalised treatments, and potentially a change in the way we treat cystic fibrosis exacerbations. The result of improved cystic fibrosis care with the aim of reducing exacerbations will improve the quality of life of both patients and their carers.

The work on metagenomic data analysis will have an impact on those studying microbiomics of disease, and more broadly the whole field of microbial ecology, due to the novel methods developed during this fellowship. The trials of metagenomics using benchtop sequencers will bring the knowledge required to start using these cutting-edge techniques in the clinical arena, complementing existing conventional microbiological diagnostics and providing a more rich picture of the microbial ecology of the respiratory tract. These techniques can be applied to the field as a whole.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>284591</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Infection and Global Health</gtr:department><gtr:description>Pseudomonas International Genomics Consortium</gtr:description><gtr:id>C9501353-191D-4660-8F61-4563A8B41735</gtr:id><gtr:impact>Whole-genome sequencing of &amp;gt;300 Pseudomonas aeruginosa isolates in Birmingham.</gtr:impact><gtr:outcomeId>rWGJtmrdmb8-1</gtr:outcomeId><gtr:partnerContribution>Management of an international network devoted to the generation, sharing and exploitation of genome data from Pseudomonas in order to benefit human health.</gtr:partnerContribution><gtr:piContribution>Sequencing of Pseudomonas aeruginosa isolates from cystic fibrosis patients and water.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Cooperation in Science and Technology (COST)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>COST Workshop</gtr:description><gtr:id>07FAA215-5BA4-4D92-9E35-CA50372BF340</gtr:id><gtr:impact>Draft manuscript outlining a novel approach to metagenomics assembly, for submission to a Nature-stable journal this year.</gtr:impact><gtr:outcomeId>YEvi6FAG2sL-1</gtr:outcomeId><gtr:partnerContribution>Provided funding for hackathon.</gtr:partnerContribution><gtr:piContribution>Co-organised a one-week 'hackathon' for development of novel methods for metagenomics assembly under the auspices of a COST action.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Laval</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>L'Institut de biologie int?grative et des syst?mes</gtr:department><gtr:description>Pseudomonas International Genomics Consortium</gtr:description><gtr:id>73715048-4F7A-4801-B98E-1E9934A508C8</gtr:id><gtr:impact>Whole-genome sequencing of &amp;gt;300 Pseudomonas aeruginosa isolates in Birmingham.</gtr:impact><gtr:outcomeId>rWGJtmrdmb8-2</gtr:outcomeId><gtr:partnerContribution>Management of an international network devoted to the generation, sharing and exploitation of genome data from Pseudomonas in order to benefit human health.</gtr:partnerContribution><gtr:piContribution>Sequencing of Pseudomonas aeruginosa isolates from cystic fibrosis patients and water.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>WebValley 2014</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>29060F77-E4A5-4B63-A6BD-3F1A0F50319F</gtr:id><gtr:impact>International students between 17 and 18 years old learnt how to operate the Oxford Nanopore portable genome sequencer, and the basics of metagenomics analysis including assembly.

Interest in studying bioinformatics and genomics at an undergraduate level.</gtr:impact><gtr:outcomeId>5464a931448cd7.23874293</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Asked to contribution expertise to drafting of POSTnote on surveillance of infectious disease</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DF21E2BC-0F41-486F-A11C-72628AFE2A3F</gtr:id><gtr:outcomeId>iF4mEaBGGJz</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Contribution to PHG Foundation Pathogen Genomics into Practice report</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0437FF82-04B4-4AC3-B667-FF9102B958BE</gtr:id><gtr:outcomeId>56e156ad1ab9c7.00637964</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.phgfoundation.org/reports/16857/</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>The Ebola virus epidemic of 2014-2016 was the largest and most lethal reported, responsible for &amp;gt;13,000 deaths. We established a portable genome surveillance laboratory in Guinea working with the European Mobile Laboratories, Public Health England and the World Health Organisation to provide real-time genomic surveillance of the outbreak from April 2015. The laboratory was based around the new Oxford Nanopore MinION portable genome sequencer.</gtr:description><gtr:id>4356A83E-6483-4768-B580-AC9B55FC264F</gtr:id><gtr:impact>After establishment of the laboratory we were able to obtain genome sequences from patient isolates within 24 hours of the patient sample being received, unprecedented anywhere in the world, but even more notable for being done in a extremely resource-limited setting. We were able to sequence &amp;gt;50% of all the Ebola cases in Guinea from April 2014 onwards. The information we generated was shared in real-time. Results were communicated to epidemiologists involved in the epidemic response via the WHO, and openly, through websites and online repositories including the ebola.Nextstrain.org website. 

The work was featured widely in the press, including an interview with Nick Loman on the BBC World Service and even on Bill Gates' Twitter feed.</gtr:impact><gtr:outcomeId>56e160709d5c78.25620338</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Established real-time Ebola genome surveillance in Guinea for World Health Organisation</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>http://lab.loman.net/2016/02/03/behind-the-paper-real-time-portable-sequencing-for-ebola-surveillance/</gtr:url><gtr:yearDevCompleted>2015</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A database of whole-genome sequences from Pseudomonas aeruginosa, collected from cystic fibrosis patients, burns patients, the hospital water and the environment.</gtr:description><gtr:id>D2B1888C-CF89-4ECF-90E5-251A19237801</gtr:id><gtr:impact>Ongoing discussions with the Department of Health over the use of whole-genome sequencing to help determine the role of hospital water in nosocomial infections, and development of a scheme of prospective pilot sequencing in three hospital centres.</gtr:impact><gtr:outcomeId>cYT47fCJfDr</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Pseudomonas aeruginosa whole-genome sequence database</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:url>http://pathogenomics.bham.ac.uk/clinicogenomics</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>I was selected to be one of the first recipients of the MinION(tm) sequencing instrument from Oxford Nanopore Technologies, a British-owned biotechnology company. This technology is able to produce whole-genome sequencers on a &amp;quot;USB stick&amp;quot; sequencer no larger than a typical smartphone.</gtr:description><gtr:id>F4B784BA-7BAB-467E-AFC4-39F5F860FADE</gtr:id><gtr:impact>Our laboratory were responsible for early beta-testing of the instrument, providing critical feedback on the instrument and laboratory and bioinformatics methods development which we shared back with the community. We were the first to generate data from this instrument (figshare.com/articles/A_P_aeruginosa_serotype_defining_single_read_from_our_first_Oxford_Nanopore_run/1052996) and then subsequently the first to publish a bacterial genome sequenced with it (www.gigasciencejournal.com/content/3/1/22). Work is ongoing in implementing real-time genome sequencing for the clinic with this technology, and for outbreaks e.g. Ebola.</gtr:impact><gtr:outcomeId>5463b4038d0ff8.99987366</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Beta testing and implementation of nanopore sequencing</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development of whole-genome sequencing service at the University of Birmingham and associated software and laboratory infrastructure to support genome sequencing for researchers at a fixed price of &amp;pound;50/sample.</gtr:description><gtr:id>39C4D995-A2A6-41A6-BDBE-E55FE5B2FB4D</gtr:id><gtr:impact>New collaborations with the University of East Anglia, University of Liverpool, University of Nottingham and internally with Institute of Microbiology and Infection researchers</gtr:impact><gtr:outcomeId>tX8Z4bdnQyA</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Implementation of whole-genome sequencing service at University of Birmingham</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The Cloud Infrastructure for Microbial Bioinformatics (CLIMB) was funded by the MRC in 2014. I am one of three research fellows on this project. I have been responsible, with Tom Connor (Cardiff), for the design and technical deployment of the &amp;gt;&amp;pound;4m investment in computer hardware and storage for this project. We have successfully deployed a cloud infrastructure using the OpenStack software across four sites. The service is currently is beta-testing phase, and has over 50 research groups using it.</gtr:description><gtr:id>C95548F2-3A5E-4032-BFD1-81EE5303DDA2</gtr:id><gtr:impact>Provided computational infrastructure report for the recent Ebola real-time genome sequencing project.</gtr:impact><gtr:outcomeId>56e169e05b7e03.49745932</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CLIMB: Cloud Infrastructure for Microbial Bioinformatics</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.climb.ac.uk</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>This is the first published piece of software for analysing data from the Oxford Nanopore sequencing platform.</gtr:description><gtr:id>E1EAA54F-D7C9-42D4-B4F7-529C2B46B1D1</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>5464aa39d3a828.05170763</gtr:outcomeId><gtr:title>poretools</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://bioinformatics.oxfordjournals.org/content/early/2014/08/19/bioinformatics.btu555.abstract</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>We developed two new open source software packages for analysis of Oxford Nanopore MinION sequencing data. The tools- nanocorrect &amp;amp; nanopolish- can be used to assemble genomes without reliance on sequencing data from other instruments was necessary to use Oxford Nanopore data. The software can also be used to detect single nucleotide variants for example in outbreak investigation.</gtr:description><gtr:id>0B1E4A40-4BF7-45E1-8B9C-3FA24D10D7D9</gtr:id><gtr:impact>The software was initially used to generate the first bacterial genome assembly, of E. coli K-12, using just nanopore data and was published in Nature Methods. Later on the software was adapted to provide highly accurate variant calls in support of the real-time Ebola genomic surveillance project (Quick, Loman, et al Nature 2016).</gtr:impact><gtr:outcomeId>56e1596da168c0.65186635</gtr:outcomeId><gtr:title>Nanopore error correction software:ananocorrect &amp; nanopolish</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://github.com/jts/nanopolish</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>CONCOCT is software for reconstructing genomes from metagenomics.</gtr:description><gtr:id>2E642CC7-49ED-4C27-8C54-985E4FEB7B57</gtr:id><gtr:impact>Publication in Nature Methods http://www.nature.com/nmeth/journal/vaop/ncurrent/full/nmeth.3103.html and featured in their research highlights http://blogs.nature.com/methagora/2014/09/microbial-sequencing-at-nature-methods.html</gtr:impact><gtr:outcomeId>5464aa06efa3e7.16187171</gtr:outcomeId><gtr:title>CONCOCT</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://github.com/BinPro/CONCOCT</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2344D403-B0CB-4E6D-85DD-A88F1C734879</gtr:id><gtr:title>Mycobacterial dihydrofolate reductase inhibitors identified using chemogenomic methods and in vitro validation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bee541eb088247fffcc18ca504f34be6"><gtr:id>bee541eb088247fffcc18ca504f34be6</gtr:id><gtr:otherNames>Mugumbate G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56dd9fb5ecc085.07347355</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEAC07D3-24A5-42F9-8550-EE9F695F58FF</gtr:id><gtr:title>Seeking the source of Pseudomonas aeruginosa infections in a recently opened hospital: an observational study using whole-genome sequencing.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6680c159d84533558ccb13e96ec45efc"><gtr:id>6680c159d84533558ccb13e96ec45efc</gtr:id><gtr:otherNames>Quick J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>5463b11204a526.15238637</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF74A2F5-D2AA-489D-B403-C50CAEBC7E11</gtr:id><gtr:title>Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f15d2dd24e0aeab128842fa5e54fa893"><gtr:id>f15d2dd24e0aeab128842fa5e54fa893</gtr:id><gtr:otherNames>Gurcha SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56dd9fb63dd898.37932178</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81646D3A-A8BA-459D-85E5-CC42CB6543F7</gtr:id><gtr:title>Defining bacterial species in the genomic era: insights from the genus Acinetobacter.</gtr:title><gtr:parentPublicationTitle>BMC microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b915cd9501fec6c89fb711f616a392af"><gtr:id>b915cd9501fec6c89fb711f616a392af</gtr:id><gtr:otherNames>Chan JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2180</gtr:issn><gtr:outcomeId>pm_14527_27_23259572</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F53DB17D-C086-4CDA-A4CC-B21EDB241E92</gtr:id><gtr:title>Real-time, portable genome sequencing for Ebola surveillance.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6680c159d84533558ccb13e96ec45efc"><gtr:id>6680c159d84533558ccb13e96ec45efc</gtr:id><gtr:otherNames>Quick J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56dd9ff6e6f511.94778092</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>593397C9-6EFB-4C56-8FF8-204CD49005EF</gtr:id><gtr:title>A cross-sectional survey of bacterial species in plaque from client owned dogs with healthy gingiva, gingivitis or mild periodontitis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf7378ce4f3c28a9eced2c0e183c1fc8"><gtr:id>cf7378ce4f3c28a9eced2c0e183c1fc8</gtr:id><gtr:otherNames>Davis IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5463b1135c2b90.95652484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13951616-AE00-4215-BAEC-97657B794D7F</gtr:id><gtr:title>Binning metagenomic contigs by coverage and composition.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de8d1caf81e365c3e9ff09579de0a6e2"><gtr:id>de8d1caf81e365c3e9ff09579de0a6e2</gtr:id><gtr:otherNames>Alneberg J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>5463b11234d705.68899478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3D0416E-C467-419E-9951-40D8E9D19895</gtr:id><gtr:title>Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f253af5292a88a639bab768f5e28957"><gtr:id>4f253af5292a88a639bab768f5e28957</gtr:id><gtr:otherNames>Remui??n MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14527_27_23613759</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FC55700-4381-4EE5-A2D4-7F456E5A3783</gtr:id><gtr:title>Extreme genetic fragility of the HIV-1 capsid.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f4570e053b2be5f88e90ad023faecef"><gtr:id>1f4570e053b2be5f88e90ad023faecef</gtr:id><gtr:otherNames>Rihn SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_14527_27_23818857</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>841C55B6-F67A-4FC9-9A90-654ADCE6C5A0</gtr:id><gtr:title>Clusters of genetically similar isolates of Pseudomonas aeruginosa from multiple hospitals in the UK.</gtr:title><gtr:parentPublicationTitle>Journal of medical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55f6c6d440adbbc77668a052f9c0d839"><gtr:id>55f6c6d440adbbc77668a052f9c0d839</gtr:id><gtr:otherNames>Martin K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-2615</gtr:issn><gtr:outcomeId>pm_14527_27_23558134</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98543FFD-14C8-4498-B3BF-42C79C89AACF</gtr:id><gtr:title>Draft Genome Sequence of Elizabethkingia meningoseptica Isolated from a Traumatic Wound.</gtr:title><gtr:parentPublicationTitle>Genome announcements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6680c159d84533558ccb13e96ec45efc"><gtr:id>6680c159d84533558ccb13e96ec45efc</gtr:id><gtr:otherNames>Quick J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5463b113344ca6.25615575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D4300E3-49FD-49CF-8748-09DD08777E4D</gtr:id><gtr:title>Characterization of mutations in the PAS domain of the EvgS sensor kinase selected by laboratory evolution for acid resistance in Escherichia coli.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b29bc4f01a1e5d64d60d2682a53ad95f"><gtr:id>b29bc4f01a1e5d64d60d2682a53ad95f</gtr:id><gtr:otherNames>Johnson MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>5463b112d0edf5.79167693</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F97A053-164D-4FDC-9E05-4C865543BC10</gtr:id><gtr:title>So you want to be a computational biologist?</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf3937fac4acc9fac11f0ebb7075b781"><gtr:id>cf3937fac4acc9fac11f0ebb7075b781</gtr:id><gtr:otherNames>Loman N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>pm_14527_27_24213777</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42676AA0-3691-49BA-BA3A-B56CB4A3D819</gtr:id><gtr:title>Rapid draft sequencing and real-time nanopore sequencing in a hospital outbreak of Salmonella.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6680c159d84533558ccb13e96ec45efc"><gtr:id>6680c159d84533558ccb13e96ec45efc</gtr:id><gtr:otherNames>Quick J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>56dd9fb52554e3.85441094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B8A75DE-28A3-44D3-8B85-9E5791C350F0</gtr:id><gtr:title>A complete bacterial genome assembled de novo using only nanopore sequencing data.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4550313d2a8286b5fb781360612b806e"><gtr:id>4550313d2a8286b5fb781360612b806e</gtr:id><gtr:otherNames>Loman NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>56dd9fb4ed99b9.61306529</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96C4EB6A-B03F-4CE9-95F5-F5A773BDAF95</gtr:id><gtr:title>Role of Faecalibacterium prausnitzii in Crohn's Disease: friend, foe, or does not really matter?</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41592addbe7ed7bd4bb66e0747bf25b4"><gtr:id>41592addbe7ed7bd4bb66e0747bf25b4</gtr:id><gtr:otherNames>Gerasimidis K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>5463b113076a71.65477090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>333DB540-2F62-4C67-AA1F-B0AF702BE7F1</gtr:id><gtr:title>Eighteenth-century genomes show that mixed infections were common at time of peak tuberculosis in Europe.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff4d62a220255bc833105a91f6993c79"><gtr:id>ff4d62a220255bc833105a91f6993c79</gtr:id><gtr:otherNames>Kay GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56dd9fb5950fa4.02833533</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>513AC6CB-0C41-418B-AF5C-D055F4010138</gtr:id><gtr:title>A reference bacterial genome dataset generated on the MinION? portable single-molecule nanopore sequencer.</gtr:title><gtr:parentPublicationTitle>GigaScience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6680c159d84533558ccb13e96ec45efc"><gtr:id>6680c159d84533558ccb13e96ec45efc</gtr:id><gtr:otherNames>Quick J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2047-217X</gtr:issn><gtr:outcomeId>5463b1534ecd96.06726559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DFD8F0E-AD60-4F87-B421-3E525B76AF12</gtr:id><gtr:title>Clonal expansion within pneumococcal serotype 6C after use of seven-valent vaccine.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4550313d2a8286b5fb781360612b806e"><gtr:id>4550313d2a8286b5fb781360612b806e</gtr:id><gtr:otherNames>Loman NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14527_27_23724086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E482A601-0C67-441A-A47A-1F987887AEE2</gtr:id><gtr:title>Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63dd6bbb5971117dc0b87c2772e59f2a"><gtr:id>63dd6bbb5971117dc0b87c2772e59f2a</gtr:id><gtr:otherNames>Webber MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>56dd9fb55e9dc3.90898340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3618CE98-C022-4190-97CE-B1867F036687</gtr:id><gtr:title>Twenty years of bacterial genome sequencing.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4550313d2a8286b5fb781360612b806e"><gtr:id>4550313d2a8286b5fb781360612b806e</gtr:id><gtr:otherNames>Loman NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>56dd9ff7277092.66547117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD6DC0AB-7D37-4BAB-B279-C624AD582EB1</gtr:id><gtr:title>High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4550313d2a8286b5fb781360612b806e"><gtr:id>4550313d2a8286b5fb781360612b806e</gtr:id><gtr:otherNames>Loman NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>pm_14527_27_22864262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>354BD34C-5CD7-411F-AADE-AB60D03F5E12</gtr:id><gtr:title>Epidemiological investigation of Pseudomonas aeruginosa isolates from a six-year-long hospital outbreak using high-throughput whole genome sequencing.</gtr:title><gtr:parentPublicationTitle>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ae66a996a5e5c01ac69e28c481e92da"><gtr:id>8ae66a996a5e5c01ac69e28c481e92da</gtr:id><gtr:otherNames>Snyder LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1025-496X</gtr:issn><gtr:outcomeId>pm_14527_27_24176582</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD1F996F-30EC-471D-8543-A271C46762A0</gtr:id><gtr:title>Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7945804f0efc4c6ad554ce8f71bee37d"><gtr:id>7945804f0efc4c6ad554ce8f71bee37d</gtr:id><gtr:otherNames>Fothergill JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5463b1126dedb4.34292298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D6BE16D-31E3-42F3-9A51-24492A7A23AE</gtr:id><gtr:title>Poretools: a toolkit for analyzing nanopore sequence data.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4550313d2a8286b5fb781360612b806e"><gtr:id>4550313d2a8286b5fb781360612b806e</gtr:id><gtr:otherNames>Loman NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>5463b11296f787.81389903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE365D20-BDF1-4A0C-88E4-93E2DCCAFAEA</gtr:id><gtr:title>Successful test launch for nanopore sequencing.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4550313d2a8286b5fb781360612b806e"><gtr:id>4550313d2a8286b5fb781360612b806e</gtr:id><gtr:otherNames>Loman NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>56dd9fb5bd0f69.58914506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>868594D7-565F-46ED-ADA4-0C8D7A7EFEE1</gtr:id><gtr:title>Reagent and laboratory contamination can critically impact sequence-based microbiome analyses.</gtr:title><gtr:parentPublicationTitle>BMC biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465c3a696ed1ce379e5bf81218c63add"><gtr:id>465c3a696ed1ce379e5bf81218c63add</gtr:id><gtr:otherNames>Salter SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1741-7007</gtr:issn><gtr:outcomeId>5463b1801c2248.49044210</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77909F7F-FB7B-4F76-9CAF-43A9A0F89E44</gtr:id><gtr:title>A culture-independent sequence-based metagenomics approach to the investigation of an outbreak of Shiga-toxigenic Escherichia coli O104:H4.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4550313d2a8286b5fb781360612b806e"><gtr:id>4550313d2a8286b5fb781360612b806e</gtr:id><gtr:otherNames>Loman NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>pm_14527_27_23571589</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J014370/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>78FE8F42-8AFB-48F8-8662-37D541AD95BF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Congenital Disorders</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>